Pharmafile Logo

Russia

- PMLiVE

Novavax starts first phase 3 COVID-19 vaccine trial in the UK

Trial is set to enrol up to 10,000 participants aged 18-84

- PMLiVE

UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus

UK human ‘challenge trial’ programme would be a world first

- PMLiVE

Relief Therapeutics seeks US emergency approval for COVID-19 drug

If granted, EUA would give approval for use in severely ill patients with no other treatment options

Havas Health & You Launches Behind the Mask, a Global Research Initiative to Document Health Experiences During the COVID-19 Pandemic and Beyond

Havas Health & You (HH&Y) have launched the details of a long-term global research project, Behind the Mask, a longitudinal, multi-armed study which focuses on documenting the ongoing evolution of...

Havas Lynx

Building Stakeholder Relationships in the New Normal

Randi Goeckeler, Global Stakeholder Relations & Strategic Engagement Leadership Expert, discusses some of the key lessons she has learned from the various roles she has held at top pharma companies....

Impetus Digital

Personalized Digital Health Coaching

Eugene Borukhovich, Chairman & COO of YourCoach.Health, discusses his transition from Global Head of Digital Health at Bayer to full-time entrepreneur. We also talk about YourCoach’s mission, the impact of COVID-19...

Impetus Digital

Empowering Medtech Innovation

Scott Phillips, President at StarFish Medical, shares his ongoing work to empower MedTech innovation in Canada and overseas. We also discuss how COVID-19 has impacted the MedTech industry and the many...

Impetus Digital

- PMLiVE

BioNTech bolsters COVID-19 vaccine capacity with Novartis deal

Deal will expand production capacity for BNT162b2 candidate

- PMLiVE

Lilly’s Olumiant combined with Gilead’s remdesivir hits the mark in COVID-19

The combination treatment hit the primary study endpoint of a reduction in recovery time

- PMLiVE

Sanofi, GSK to launch human trials of COVID-19 vaccine

Vaccine combines Sanofi’s baculovirus expression system and GSK’s AS03 adjuvant

- PMLiVE

Regeneron launches phase 3 COVID-19 antibody trial in the UK

Drug cocktail will be evaluated in patients hospitalised with COVID-19

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links